![]() |
|
|

* Osteoporosis Prevention and Treatment Center and Bone and Mineral Metabolism Laboratory, Departments of Physical Medicine & Rehabilitation, Medicine, and Nutrition, Davis Medical Research Center, The Ohio State University, Columbus, OH 43210;
Department of Endocrinology, Medical Faculty, University of Rijeka, Croatia; and
** Department of Statistics, The Ohio State University, Columbus, OH 43210
3To whom correspondence should be addressed. E-mail: matkovic.1{at}osu.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: calcium adolescence peak bone mass bone growth
Calcium and proteins may be important determinants of peak bone mass in young adults by influencing bone accretion during growth (1). Adolescence in particular may be a critical period when inadequate calcium nutrition is detrimental to skeletal maturation as calcium requirements are highest during this period of life (2). To understand further potential nutritional determinants of peak bone mass, we conducted a randomized clinical trial with calcium supplementation in a group of young females; in addition, we followed a cohort of young females accustomed to a higher intake of dairy products as a part of an observational study (3). Both studies extended from childhood to young adulthood. Here we report data for several skeletal regions of interest measured during late adolescence.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Participants of the clinical trial were randomly assigned to receive either calcium citrate-malate (CCM)4 supplementation (1000 mg/4 pills/d) or placebo. Procter & Gamble Company provided CCM and placebo pills. Subjects were given a 6-mo supply of pills at each visit; additional pills were mailed for delayed appointments. Subjects were instructed to take 2 pills in the AM and 2 pills in the PM. Compliance was monitored by pill counts. Participants in the observational component of the study did not receive any intervention, but their dietary habits were monitored; milk was the main source of dietary calcium in the group. There were a maximum of 15 visits (semiannual measurements) for the clinical trial participants and 8 visits (annual measurements) for the dairy group over the 7-y period. By age 15 y there were 103 subjects in the calcium group, 123 in the placebo group, and 88 in the dairy group.
Bone mineral areal density of the hip and spine were measured during the last 3 y and forearm by peripheral Quantitative Computed Tomography (pQCT) at the end of the study (data reported here) while total body and forearm bone mineral areal density, as well as metacarpal radiogrammetry, was measured over the 7-y period (3). Bone mineral areal density measurements were done by dual X-ray absorptiometry (DXA) (1.3q software, GE-Lunar DPX-L). Volumetric bone mineral density measurements of the nondominant radius at the proximal sites (33%) were performed using a pQCT (Norland-Stratec XCT 2000) densitometer with contour, peel, and separation modes of 2,2,2. Nutritional status was determined from 3-d dietary food records using Nutritionist III, v8.5 (Hearst). Total calcium intake in the supplemented group included dietary calcium plus pill calcium adjusted for compliance.
This long-term study allowed us to evaluate the effectiveness of calcium supplementation and dairy products on the bone accretion until the time when most of the bone mass had been accumulated. Pragmatic intent-to-treat analyses were first conducted to measure the effectiveness of calcium supplementation, irrespective of compliance. However, this approach is not without controversy; as compliance decreases, treatment effectiveness decreases, regardless of its efficacy (5,6). Biologic efficacy of calcium was therefore evaluated in a subgroup analysis according to post-hoc stratification based on the average total cumulative calcium intake over time (above/below the median of 1006 mg/d). This led to the formation of a high calcium intake subgroup and a low calcium intake subgroup.
The comparison between the groups was done by the multiple-response ANOVA. The S-plus 2000 package for Windows, Professional Release 3 (Insightful) and Data Desk version 6.1.1 for Macintosh (Data Description) were used for all the statistical analyses.
| RESULTS |
|---|
|
|
|---|
|
|
By the average age 15 y, the dairy group subjects remained significantly taller, and had higher dietary calcium and protein intakes as compared to calcium supplemented and placebo groups.
Bone mineral areal density of the anterior posterior (AP) spine (L2-L4) increased in all three groups from the average age 15 to 18 y (Fig. 2). There was no difference in bone mineral density (BMD) of the lumbar spine between the calcium supplemented and the placebo group (P = 0.313). However, the dairy group had higher bone mineral density of the spine at age
15 y, and this was maintained up to the age of
18 y. Supplemented individuals had significantly (P = 0.0024) higher (3%) BMD at femur trochanter (Fig. 3); however, at the femoral neck, the difference (1.8%) was not significant (P = 0.234) (Fig. 4). Bone mineral density of the hip in the dairy group was similar to that of the calcium-supplemented individuals. The above differences were established by age
15 y and maintained till age
18 y when BMD at the hip in all three groups started to decline.
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
830 mg/d did not influence bone mineral areal density of the AP lumbar spine; however, dairy group individuals had much higher density values than did their clinical trial counterparts. The dairy group subjects were taller and had higher bone volume of the radius as presented in the total cross-sectional area. Their calcium intake from dairy products was almost double at baseline, and they had
20% higher protein intake in comparison to the subjects selected for the clinical trial. The differences in bone volume between dairy and clinical trial groups could simply be explained due to more favorable impact of milk (due to its mineral and protein content) (911) on bone expansion during early growth, childhood years, and/or by a combination of other healthy life-style factors, such as physical exercise, associated with milk-drinking habits (12,13); however, we do not have evidence to support the latter. Periosteal bone expansion, irrespective of density, contributes to bone strength. The above findings are clinically important and indicate a need for an intervention study with dairy and calcium supplements early in childhood. All clinical studies with calcium or dairy products supplementation in children and adolescents reported positive effect of intervention on bone mass (1422). However, all these studies were too brief to address the issue of peak bone mass. The increase in bone mass observed in those studies could be explained to a large extent by the remodeling transient phenomenon (23). In some of the studies reported earlier, the difference in bone mass between the groups diminished after calcium intervention was discontinued (24,25), indicating that the gain in bone accretion was lost as a result of the second transient (23). In other studies, the effects of intervention were maintained (22,26,27). This may be specific to the calcium source and/or the level of habitual dietary calcium intake in the population under study. Given that bone mineral density of the hip and the forearm of young females in this study reached a higher level after a prolonged calcium supplementation, a follow-up study is necessary to resolve this issue.
In conclusion, this study indicated that calcium and dairy products influence bone mass acquisition, leading to a higher peak bone mass. Calcium exerts its action on bone accretion during growth primarily by influencing volumetric bone mineral density, while dairy products may have an additional impact on bone growth and periosteal bone expansion.
| FOOTNOTES |
|---|
2 Supported by grants from NIH RO1 AR4073601A1, CRC-NIH M01-RR00034, NRICGP/USDA-372007586, Procter & Gamble Company, National Dairy Council, Ross Products Division Abbott Laboratories, and General Mills Com. ![]()
4 Abbreviations used: AP, anterior posterior; BMD, bone mineral density; CCM, calcium citrate-malate; DXA, dual X-ray absorptiometry; pQCT, peripheral Quantitative Computed Tomography. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Heaney, R. P., Abrams, S., Dawson-Hughes, B., Looker, A., Marcus, R., Matkovic, V. & Weaver, C. (2000) Peak bone mass. Osteoporosis Int 11:985-1009.[Medline]
2. Matkovic, V., Fontana, D., Tominac, C., Goel, P. & Chesnut, C. H. (1990) Factors which influence peak bone mass formation: A study of calcium balance and the inheritance of bone mass in adolescent females. Am. J. Clin. Nutr. 52:878-888.
3. Matkovic, V., Badenhop-Stevens, N. E., Landoll, J. D., Goel, P. & Li, B. (2002) Long term effect of calcium supplementation and dairy products on bone mass of young females. J. Bone Miner. Res. 17:S172.
4. Matkovic, V. & Heaney, R. P. (1992) Calcium balance during human growth: evidence for threshold behavior. Am. J. Clin. Nutr. 55:992-996.
5. Everitt, B. S. & Pickles, A. (1999) Statistical Aspects of the Design and Analysis of Clinical Trials 1999 Imperial College Press London, UK.
6. Sommer, A. & Zeger, S. L. (1991) On estimating efficacy from clinical trials. Statist. Med. 10:45-52.
7. Matkovic, V. (1991) Calcium metabolism and calcium requirements during skeletal modeling and consolidation of bone mass. Am. J. Clin. Nutr. 54:245S-260S.
8. Matkovic, V., Jelic, T., Wardlaw, G. M., Ilich, J. Z., Goel, P. K., Wright, J. K., Andon, M. B., Smith, K. T. & Heaney, R. P. (1994) Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J. Clin. Invest. 93:799-808.
9. Orr, J. B. (1928) Milk consumption and the growth of school children. Lancet 1:202-203.
10. Garn, S. M., Rohmann, C. G., Behar, M., Viteri, F. & Gozman, M. (1964) Compact bone deficiency in protein-calorie malnutrition. Science 145:1444-1445.
11. Black, R. E., Williams, S. M., Jones, I. E. & Goulding, A. (2002) Children who avoid drinking cow milk have low dietary intakes and poor bone health. Am. J. Clin. Nutr. 76:675-680.
12. Specker, B. & Binkley, T. (2003) Randomized trial of physical activity and calcium supplementation on bone mineral content in 35 year old children. J. Bone Miner. Res. 18:885-892.[Medline]
13. Iuliano-Burns, S., Saxon, L., Naughton, G., Gibbons, K. & Bass, S. L. (2003) Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial. J. Bone Miner. Res. 18:156-162.[Medline]
14. Johnston, C. C., Jr, Miller, J. Z., Slemenda, C. W., Reister, T. K., Hui, S., Christian, J. C. & Peacock, M. (1992) Calcium supplementation and increases in bone mineral density in children. N. Eng. J. Med. 327:82-87.[Abstract]
15. Lloyd, T., Andon, M. B., Rollings, N., Martel, J. K., Landis, R. J., Demers, L. M., Eggli, D. F., Kieselhorst, K. & Kulin, H. E. (1993) Calcium supplementation and bone mineral density in adolescent girls. J. Am. Med. Assoc. 270:841-844.[Abstract]
16. Lee, W.T.K., Leung, S.S.F., Wang, S. F., Xu, Y. C., Zeng, W. P., Lau, J., Oppenheimer, S. J. & Cheng, J.C.Y. (1994) Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. Am. J. Clin. Nutr. 60:744-750.
17. Cadogan, J., Eastell, R., Jones, N. & Barker, M. E. (1997) Milk intake and bone mineral acquisition in adolescent girls: randomized, controlled intervention trial. Br. Med. J. 315:1255-1260.
18. Chan, G. M., Hoffman, K. & McMurray, M. (1995) Effect of dairy products on bone and body composition in pubertal girls. J. Pediatrics 126:551-556.[Medline]
19. Bonjour, J. P., Carrie, A. L., Ferrarri, S., Clavien, H., Slosman, D., Theintz, G. & Rizzoli, R. (1997) Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled, trial. J. Clin. Invest. 99:1287-1294.[Medline]
20. Nowson, C. A., Green, R. M., Hopper, J. L., Sherwin, A. J., Young, D., Kaymakci, B., Guest, C. S., Schmid, M., Larkins, R. G. & Wark, J. D. (1997) A co-twin study of the effect of calcium supplementation on bone density during adolescence. Osteoporosis Int 7:219-225.[Medline]
21. Dibba, B., Prentice, A., Ceesay, M., Stirling, D. M., Cole, T. J. & Poskitt, E. M. E. (2000) Effect of calcium supplementation on bone mineral accretion in Gambian children accustomed to a low-calcium diet. Am. J. Clin. Nutr. 71:544-549.
22. Merrilees, M. J., Smart, E. J., Gilchrist, N. L., Frampton, C., Turner, J. G., Hooke, E., March, R. L. & Maguire, P. P. (2000) Effects of dairy food supplements on bone mineral density in teenage girls. Eur. J. Nutr. 39:256-262.[Medline]
23. Heaney, R. P. (1995) Interpreting trials of bone-active agents. Am. J. Med. 98:329-330.[Medline]
24. Slemenda, C., Peacock, M., Hui, S., Zhou, L. & Johnston, C. C. (1997) Reduced rates of skeletal remodeling are associated with increased bone mineral density during the development of peak bone mass. J. Bone Miner. Res. 12:676-682.[Medline]
25. Lee, W.T.K., Leung, S.S.F., Leung, D.M.Y. & Cheng, J.C.Y. (1996) A follow-up study on the effects of calcium-supplement withdrawal and puberty on bone acquisition of children. Am. J. Clin. Nutr. 64:71-77.
26. Bonjour, J.-P., Chevalley, T., Ammann, P., Slosman, D. & Rizzoli, R. (2001) Gain in bone mineral mass in prepubertal girls 35 years after discontinuation of calcium supplementation: a follow-up study. Lancet 358:1208-1212.[Medline]
27. Dibba, B., Prentice, A., Ceesay, M., Mendy, M., Darboe, S., Stirling, D. M., Cole, T. J. & Poskitt, E.M.E. (2002) Bone mineral contents and plasma osteocalcin concentrations of Gambian children 12 and 24 mo after the withdrawal of a calcium supplement. Am. J. Clin. Nutr. 76:681-686.
This article has been cited by other articles:
![]() |
S. A. Atkinson, G. P. McCabe, C. M. Weaver, S. A. Abrams, and K. O. O'Brien Are Current Calcium Recommendations for Adolescents Higher than Needed to Achieve Optimal Peak Bone Mass? The Controversy J. Nutr., June 1, 2008; 138(6): 1182 - 1186. [Full Text] [PDF] |
||||
![]() |
H. L Lambert, R. Eastell, K. Karnik, J. M Russell, and M. E Barker Calcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y follow-up Am. J. Clinical Nutrition, February 1, 2008; 87(2): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Fiorito, D. C. Mitchell, H. Smiciklas-Wright, and L. L. Birch Girls' Calcium Intake Is Associated with Bone Mineral Content During Middle Childhood J. Nutr., May 1, 2006; 136(5): 1281 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parelman, B. Stoecker, A. Baker, and D. Medeiros Iron Restriction Negatively Affects Bone in Female Rats and Mineralization of hFOB Osteoblast Cells. Experimental Biology and Medicine, April 1, 2006; 231(4): 378 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, A. Lyytikainen, H. Kroger, C. Lamberg-Allardt, M. Alen, A. Koistinen, Q. J. Wang, M. Suuriniemi, H. Suominen, A. Mahonen, et al. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1115 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Tylavsky Nutrition Influences Bone Growth in Children J. Nutr., March 1, 2004; 134(3): 689S - 690. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||